Through the 90-day period concluding January 09, 2026, Celldex Therapeutics's top three insider stakeholders include President & Ceo Anthony S Marucci (40.28K shares), Svp And Cfo Samuel Bates Martin (32.94K shares), Svp & General Counsel Freddy A. Jimenez (30.80K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Anthony S Marucci | President & Ceo | 40,284 | 12 Nov, 2024 |
| Samuel Bates Martin | Svp And Cfo | 32,942 | 06 Jan, 2026 |
| Freddy A. Jimenez | Svp & General Counsel | 30,796 | 08 Dec, 2025 |
| Richard M. Wright | 20,833 | 17 Nov, 2025 | |
| Ronald Pepin | Sr. Vp & Cbo | 20,097 | 17 Dec, 2025 |
| Diane C. Young | Svp And Chief Medical Officer | 17,115 | 13 Jun, 2024 |
| Margo Heath-Chiozzi | Svp Of Regulatory Affairs | 13,383 | 05 Jun, 2024 |
| Elizabeth Crowley | Sr. Vp & Cpdo | 9,074 | 18 Jun, 2024 |
| Tibor Keler | Executive Vp & Cso | 7,357 | 09 Dec, 2022 |
| James J Marino | 2,204 | 20 Nov, 2024 | |
| Sarah Cavanaugh | Svp Of Corp Affairs & Admin. | 1,860 | 03 Jun, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 02 Jan, 2026 | Samuel Bates Martin | Common Stock | A | 4,817 | $10.38 | 32,942 | D | M |
| 15 Dec, 2025 | Ronald Pepin | - | - | 20,097 | D | |||
| 15 Dec, 2025 | Ronald Pepin | Common Stock | A | 8,333 | $9.02 | 9,097 | D | M |
| 15 Dec, 2025 | Ronald Pepin | Common Stock | A | 11,000 | $2.78 | 20,097 | D | M |
| 15 Dec, 2025 | Ronald Pepin | - | - | 9,097 | D | |||
| 04 Dec, 2025 | Freddy A. Jimenez | - | - | 30,796 | D | |||
| 04 Dec, 2025 | Freddy A. Jimenez | Common Stock | D | 4,166 | $29.10 | 30,796 | D | S |
| 13 Nov, 2025 | Richard M. Wright | Common Stock | A | 26,672 | $10.38 | 54,381 | D | M |
| 13 Nov, 2025 | Richard M. Wright | - | - | 54,381 | D | |||
| 13 Nov, 2025 | Richard M. Wright | Common Stock | A | 6,876 | $9.02 | 27,709 | D | M |
| 13 Nov, 2025 | Richard M. Wright | - | - | 70,131 | D | |||
| 13 Nov, 2025 | Richard M. Wright | Common Stock | A | 15,750 | $22.48 | 70,131 | D | M |
| 13 Nov, 2025 | Richard M. Wright | - | - | 20,833 | D | |||
| 13 Nov, 2025 | Richard M. Wright | - | - | 27,709 | D | |||
| 13 Nov, 2025 | Richard M. Wright | Common Stock | D | 49,298 | $24.00 | 20,833 | D | S |
| 13 Aug, 2025 | Freddy A. Jimenez | Common Stock | D | 430 | $25.42 | 34,962 | D | S |
| 13 Aug, 2025 | Freddy A. Jimenez | Common Stock | D | 341 | $23.95 | 35,392 | D | S |
| 18 Nov, 2024 | James J Marino | - | - | 2,204 | D | |||
| 18 Nov, 2024 | James J Marino | Common Stock | D | 10,500 | $0.00 | 2,204 | D | G |
| 11 Nov, 2024 | Anthony S Marucci | - | - | 40,284 | D |